Patents by Inventor Joanne Wang

Joanne Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
    Patent number: 10912823
    Abstract: Methods for treating melanin-related afflictions of the skin, such as hyperpigmentation, are provided. The methods comprise administering a composition comprising BoNT/DC.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: February 9, 2021
    Assignee: Allergan, Inc.
    Inventors: Birgitte P.S. Jacky, Shiazah Z. Malik, Joanne Wang, Yi Liu, Amy Brideau-Andersen, Lance E. Steward, Linh Q. Le, Edward C. Hsai
  • Immuno-based retargeted endopeptidase activity assays
    Patent number: 10900967
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: January 26, 2021
    Assignee: Allergan, Inc.
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
    Publication number: 20200392212
    Abstract: The present specification discloses SNAP-25 compositions, methods of making ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing ?-BoNT/A antibodies.
    Type: Application
    Filed: July 2, 2020
    Publication date: December 17, 2020
    Inventors: Ester Fernandez-Salas, Joanne Wang, Patton Garay, Lina S. Wong, D. Dianne Hodges, Kei Rogers Aoki
  • IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
    Publication number: 20200369749
    Abstract: The present specification discloses SNAP-25 compositions, methods of making ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing ?-BoNT/A antibodies.
    Type: Application
    Filed: July 2, 2020
    Publication date: November 26, 2020
    Inventors: Ester Fernandez-Salas, Joanne Wang, Patton Garay, Lina S. Wong, D. Dianne Hodges, Kei Rogers Aoki
  • Immuno-based botulinum toxin serotype A activity assays
    Patent number: 10703806
    Abstract: The present specification discloses SNAP-25 compositions, methods of making ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing ?-BoNT/A antibodies.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: July 7, 2020
    Assignee: Allergan, Inc.
    Inventors: Ester Fernandez-Salas, Joanne Wang, Patton Garay, Lina S. Wong, D. Dianne Hodges, Kei Rogers Aoki
  • IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
    Publication number: 20190324041
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Application
    Filed: July 8, 2019
    Publication date: October 24, 2019
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A
    Patent number: 10451621
    Abstract: The present specification discloses methods for detecting extremely low amounts of botulinum neurotoxin serotype A in samples, including complex matrices like blood, plasma, and serum.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: October 22, 2019
    Assignee: Allergan, Inc.
    Inventors: Joanne Wang, Anuradha Dixit, Kenton B. Abel, Swati Gupta, Ester Fernandez-Salas
  • Immuno-based retargeted endopeptidase activity assays
    Patent number: 10345306
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: July 9, 2019
    Assignee: Allergan, Inc.
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN
    Publication number: 20180344820
    Abstract: Methods for treating melanin-related afflictions of the skin, such as hyperpigmentation, are provided. The methods comprise administering a composition comprising BoNT/DC.
    Type: Application
    Filed: May 30, 2018
    Publication date: December 6, 2018
    Inventors: Birgitte P.S. Jacky, Shizazh Z. Malik, Joanne Wang, Yi Liu, Amy Brideau-Andersen, Lance E. Steward, Linh Q. Le, Edward C. Hsai
  • IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
    Publication number: 20170283487
    Abstract: The present specification discloses SNAP-25 compositions, methods of making ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing ?-BoNT/A antibodies.
    Type: Application
    Filed: January 6, 2017
    Publication date: October 5, 2017
    Inventors: Ester Fernandez-Salas, Joanne Wang, Patton Garay, Lina S. Wong, D. Dianne Hodges, Kei Rogers Aoki
  • IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
    Publication number: 20170248602
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Application
    Filed: May 12, 2017
    Publication date: August 31, 2017
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
    Publication number: 20170218334
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: April 17, 2017
    Publication date: August 3, 2017
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Ester Fernandez-Salas
  • Immuno-based retargeted endopeptidase activity assays
    Patent number: 9651553
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: May 16, 2017
    Assignee: Allergan, Inc.
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • Cells useful for immuno-based botulinum toxin serotype A activity assays
    Patent number: 9625447
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: April 18, 2017
    Assignee: Allergan, Inc.
    Inventors: Hong Zhu, Joanne Wang, Birgitte P. S. Jacky, D. Dianne Hodges, Fernandez-Salas Ester
  • Generating and enforcing a holistic quality of service policy in a network
    Patent number: 9413611
    Abstract: A method may include receiving a request to establish a quality of service (QoS) policy that identifies a desired QoS associated with traffic being transported by a network; generating a QoS model based on the identified desired QoS, where the QoS model includes a class of service (CoS) and corresponding forwarding priorities associated with the traffic; retrieving a service level agreement (SLA), associated with a client device that is interconnected to a network node associated with the network, where the SLA includes a particular CoS and corresponding other forwarding priorities for packets associated with the client device; creating a QoS provisioning policy based on the QoS model and the SLA, where the creating includes mapping the CoS to the particular CoS or mapping the forwarding priorities to the other forwarding priorities; and transmitting, to the network node, the QoS provisioning policy that permits the network node to process the packets in a manner that complies with the QoS model or the SLA.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: August 9, 2016
    Assignee: Juniper Networks, Inc.
    Inventors: Shaogang Chen, Vibhu Pratap, Suganthi Srinivasan, Fan Jiao, Joanne Wang, Dejan Mihajlovic
  • Immuno-based botulinum toxin serotype A activity assays
    Patent number: 9249216
    Abstract: The present specification discloses SNAP-25 compositions, methods of making ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, ?-SNAP-25 antibodies that bind an epitope comprising a carboxyl-terminus at the P1 residue from the BoNT/A cleavage site scissile bond from a SNAP-25 cleavage product, methods of detecting BoNT/A activity, and methods of detecting neutralizing ?-BoNT/A antibodies.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: February 2, 2016
    Assignee: Allergan, Inc.
    Inventors: Ester Fernandez-Salas, Joanne Wang, Patton Garay, Lina S. Wong, D. Diane Hodges, Kei Roger Aoki
  • IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
    Publication number: 20150301050
    Abstract: The present specification discloses a retargeted endopeptidase pharmaceutical wherein the activity has been determined by the methods disclosed.
    Type: Application
    Filed: April 24, 2015
    Publication date: October 22, 2015
    Inventors: Joanne Wang, Hong Zhu, Dianne D. Hodges, Ester Fernandez-Salas
  • GENERATING AND ENFORCING A HOLISTIC QUALITY OF SERVICE POLICY IN A NETWORK
    Publication number: 20140341027
    Abstract: A method may include receiving a request to establish a quality of service (QoS) policy that identifies a desired QoS associated with traffic being transported by a network; generating a QoS model based on the identified desired QoS, where the QoS model includes a class of service (CoS) and corresponding forwarding priorities associated with the traffic; retrieving a service level agreement (SLA), associated with a client device that is interconnected to a network node associated with the network, where the SLA includes a particular CoS and corresponding other forwarding priorities for packets associated with the client device; creating a QoS provisioning policy based on the QoS model and the SLA, where the creating includes mapping the CoS to the particular CoS or mapping the forwarding priorities to the other forwarding priorities; and transmitting, to the network node, the QoS provisioning policy that permits the network node to process the packets in a manner that complies with the QoS model or the SLA.
    Type: Application
    Filed: July 31, 2014
    Publication date: November 20, 2014
    Inventors: Shaogang CHEN, Vibhu PRATAP, Suganthi SRINIVASAN, Fan JIAO, Joanne WANG, Dejan MIHAJLOVIC
  • Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A
    Publication number: 20140248644
    Abstract: The present specification discloses methods for detecting extremely low amounts of botulinum neurotoxin serotype A in samples, including complex matrices like blood, plasma, and serum.
    Type: Application
    Filed: December 28, 2012
    Publication date: September 4, 2014
    Inventors: Joanne Wang, Anuradha Dixit, Kenton B. Abel, Swati Gupta, Ester Fernandez-Salas
  • Generating and enforcing a holistic quality of service policy in a network
    Patent number: 8797867
    Abstract: A method may include receiving a request to establish a quality of service (QoS) policy that identifies a desired QoS associated with traffic being transported by a network; generating a QoS model based on the identified desired QoS, where the QoS model includes a class of service (CoS) and corresponding forwarding priorities associated with the traffic; retrieving a service level agreement (SLA), associated with a client device that is interconnected to a network node associated with the network, where the SLA includes a particular CoS and corresponding other forwarding priorities for packets associated with the client device; creating a QoS provisioning policy based on the QoS model and the SLA, where the creating includes mapping the CoS to the particular CoS or mapping the forwarding priorities to the other forwarding priorities; and transmitting, to the network node, the QoS provisioning policy that permits the network node to process the packets in a manner that complies with the QoS model or the SLA.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: August 5, 2014
    Assignee: Juniper Networks, Inc.
    Inventors: Shaogang Chen, Vibhu Pratap, Suganthi Srinivasan, Fan Jiao, Joanne Wang, Dejan Mihajlovic